Adaptive Biotechnologies Corporation (ADPT) vs Heartflow, Inc. Common Stock (HTFL)

A side-by-side comparison of Adaptive Biotechnologies Corporation and Heartflow, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ADPT vs HTFL

growth of $100 · dividends reinvested · last 1y
ADPT +138.0% (+138.0%/yr)HTFL +81.6% (+81.6%/yr)ADPT compounded faster over this window
100150200250Start $1002026$238$182
ADPT HTFL

ADPT vs HTFL: by the numbers

  • •ADPT is the larger company ($4.51B vs $4.38B market cap).
  • •Both run net losses; ADPT's is the smaller (-20.73% vs -55.82% net margin).

Metrics side by side

Valuation

MetricADPTHTFL
P/S ratio14.6520.65
P/B ratio31.5815.66

Profitability

MetricADPTHTFL
Gross margin75.44%80.08%
Operating margin-20.62%-34.31%
Net margin-20.73%-55.82%
ROE-44.68%-42.32%
ROIC-6.67%-23.69%

Growth (annualized)

MetricADPTHTFL
Revenue CAGR (5Y)18.22%N/A
Total return CAGR (5Y)-1.77%N/A

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.